Standard Versus Transepithelial Corneal Crosslinking
NCT02349165
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class
Conditions
Keratoconus
Interventions
PROCEDURE:
Transepithelial versus epithelium-off CXL
DRUG:
Ricrolin TE
DRUG:
Isotonic riboflavin
Sponsor
Nienke Soeters
Collaborators
[object Object]
[object Object]